Weak consumption, an aging population and an exodus of personal wealth from the country put China on a perilous path.

But the interest goes beyond internet companies and smartphone makers. Investors are betting robotics makers will benefit ...

China faces a “toxic combination” of deflation and devaluation which Japan did not experience. It may be a sign of greater ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

The Caixin/S&P Global manufacturing purchasing manager's index came in at 50.1 in January, missing Reuters poll forecast of ...

As the Chinese lunar new year begins, investors will be wondering whether allocating to the world’s second-largest economy ...

The pervasiveness of change in the atmosphere has sent some citizens into an intense spell of contemplation — this after China’s economy repeatedly failed to meet expectations on nearly every ...

China’s No 4 political figure has rallied ... pledged further support for the development of the private economy, which is responsible for more than 60 per cent of the nation’s gross domestic ...

Such developments are giving some credence to the aphorism that China, now the world’s second largest economy but facing major headwinds, will “grow old before it grows rich.” Government ...